20-50892557-G-C

Variant summary

Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong

The NM_001282531.3(ADNP):​c.2157C>G​(p.Tyr719*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: not found (cov: 32)

Consequence

ADNP
NM_001282531.3 stop_gained

Scores

1
6

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:12O:1

Conservation

PhyloP100: -1.13
Variant links:
Genes affected
ADNP (HGNC:15766): (activity dependent neuroprotector homeobox) Vasoactive intestinal peptide is a neuroprotective factor that has a stimulatory effect on the growth of some tumor cells and an inhibitory effect on others. This gene encodes a protein that is upregulated by vasoactive intestinal peptide and may be involved in its stimulatory effect on certain tumor cells. The encoded protein contains one homeobox and nine zinc finger domains, suggesting that it functions as a transcription factor. This gene is also upregulated in normal proliferative tissues. Finally, the encoded protein may increase the viability of certain cell types through modulation of p53 activity. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 14 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 10 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 20-50892557-G-C is Pathogenic according to our data. Variant chr20-50892557-G-C is described in ClinVar as [Pathogenic]. Clinvar id is 139635.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-50892557-G-C is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADNPNM_001282531.3 linkc.2157C>G p.Tyr719* stop_gained Exon 6 of 6 ENST00000621696.5 NP_001269460.1 Q9H2P0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADNPENST00000621696.5 linkc.2157C>G p.Tyr719* stop_gained Exon 6 of 6 5 NM_001282531.3 ENSP00000483881.1 Q9H2P0

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
35
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:12Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder Pathogenic:8Other:1
-
Pediatric Department, Xiangya Hospital, Central South University
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: research

- -

Apr 27, 2022
Revvity Omics, Revvity
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 01, 2014
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

-
GeneReviews
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

Pathogenic variant in exon 4; associated with later onset of walking and higher pain threshold than other ADNP pathogenic variants -

May 25, 2020
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Based on the classification scheme VCGS_Germline_v1.1.0, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0107 - This gene is known to be associated with autosomal dominant disease. (N) 0204 - Variant is predicted to result in a truncated protein with more than 1/3 of the protein affected. (P) 0251 - Variant is heterozygous. (N) 0301 - Variant is absent from gnomAD. (P) 0600 - Variant is located upstream of an annotated domain or motif (Homeodomain; NCBI, PDB). (N) 0701 - Comparable variants have very strong previous evidence for pathogenicity (ClinVar). (P) 0801 - Strong previous evidence of pathogenicity in unrelated individuals (ClinVar, Deciphering Developmental Disorders Study, Helsmoortel, C. et al. (2014)). (P) 1102 - Strong phenotype match. (P) 1203 - Variant shown to be de novo in proband (parental status confirmed). (P) -

Jan 15, 2024
Baylor Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 01, 2019
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Aug 22, 2023
3billion
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.007%). Predicted Consequence/Location: Missense variant Functional studies provide supporting evidence of the variant having a damaging effect on the gene or gene product (PMID: 22131351, 23748425). In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.78 (>=0.6, sensitivity 0.68 and specificity 0.92)]. Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (PMID: 11174330).The variant has been observed in at least two similarly affected unrelated individuals (PMID: 11174330, 20641121, 27532257, 29121657).The variant has been previously reported as assumed (i.e. paternity and maternity not confirmed) de novo in at least one similarly affected unrelated individual (3billion dataset).The variant has been reported to co-segregate with the disease in at least 3 similarly affected relatives/individuals in the same family or similarly affected unrelated families (PMID: 11174330). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -

Oct 01, 2021
Illumina Laboratory Services, Illumina
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The ADNP c.2157C>G (p.Tyr719Ter) variant is a stop-gained variant that is predicted to result in a premature termination or absence of the protein. This variant is located in the last exon and may escape nonsense-mediated decay. Across a selection of literature, the p.Tyr719Ter variant has been reported in a de novo heterozygous state in at least eight probands with a phenotype consistent with ADNP-related neurodevelopmental disorder (Helsmoortel et al. 2014; Pescosolido et al. 2014; Gozes et al. 2017). Van Dijck et al. 2019) noted that individuals with the p.Tyr719Ter variant walk later and have a higher pain threshold than individuals with other pathogenic ADNP variants. This variant is not found in version 2.1.1 or version 3.1.1 of the Genome Aggregation Database despite its location in a region of good sequencing coverage, which suggests the variant is rare. Based on the collective evidence, the p.Tyr719Ter variant is classified as pathogenic for ADNP-related neurodevelopmental disorder. -

not provided Pathogenic:2
Jun 20, 2022
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 384 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29724491, 25057125, 28407407, 28221363, 24531329, 29911927, 29475819, 31785789, 33004838, 32758449, 31526516) -

Oct 06, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 139635). This premature translational stop signal has been observed in individual(s) with Helsmoortel-van der Aa syndrome (PMID: 28221363, 28708303). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr719*) in the ADNP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 384 amino acid(s) of the ADNP protein. -

Inborn genetic diseases Pathogenic:1
Apr 08, 2015
Ambry Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

ADNP-related disorder Pathogenic:1
Aug 11, 2024
PreventionGenetics, part of Exact Sciences
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

The ADNP c.2157C>G variant is predicted to result in premature protein termination (p.Tyr719*). This variant has been reported in patients with intellectual disability, autism and dysmorphic features, and in most cases it was reported to be de novo (see, for example, Helsmoortel et al. 2014. PubMed ID: 24531329; Takenouchi et al. 2017. PubMed ID: 28407407; Van Dijck et al. 2018. PubMed ID: 29724491). In vitro experimental studies indicate this variant affects protein function (Gozes et al. 2017. PubMed ID: 28221363; Cappuyns et al. 2018. PubMed ID: 29911927). This variant has not been reported in a large population database, indicating this variant is rare. Nonsense variants in ADNP are expected to be pathogenic. This variant is interpreted as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.59
D
BayesDel_noAF
Benign
-0.49
CADD
Benign
22
DANN
Benign
0.86
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.29
N
Vest4
0.93
GERP RS
-12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs587777526; hg19: chr20-49509094; COSMIC: COSV104421310; COSMIC: COSV104421310; API